Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages

Figure 1

Graphs showing the success rates (with standard error) of glaucoma surgery, (a) at postoperative year 1 and (b) at final visits, between the preoperative intravitreal bevacizumab (IVB) group and the control group, according to the extent of peripheral anterior synechiae (PAS).

(a)

(b)